Gender-based evaluation of the XIENCE V™ everolimus-eluting coronary stent system: Clinical and angiographic results from the SPIRIT III randomized trial

Catheterization and Cardiovascular Interventions

Volumn 74, Issue 5, 2009, Pages 719-727

  Lansky, Alexandra J ^a   Ng, Vivian G ^a   Mutlu, Halil ^a   Cristea, Ecaterina ^a   Guiran, Julian Benetato ^b   Midei, Mark ^c   Newman, William ^d   Sanz, Mark ^e   Sood, Poornima ^f   Doostzadeh, Julie ^f   Su, Xiaolu ^f   White, Roseann ^f   Cao, Sherry ^f   Sudhir, Krishnankutty ^f   Stone, Gregg W ^a  

^a NewYork Presbyterian Hospital   (United States)

^b BROOKLYN HOSPITAL CENTER   (United States)

^c St Joseph Medical Center   (United States)

^d WAKEMED HEALTH AND HOSPITALS   (United States)

^e St Patrick Hospital and Health Sciences Center   (United States)

^f ABBOTT VASCULAR   (United States)

Author keywords

Drug eluting stent; Percutaneous coronary intervention; Women

Indexed keywords

EVEROLIMUS; PACLITAXEL;

ADULT; AGE DISTRIBUTION; AGED; ANGIOCARDIOGRAPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; GENDER; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; POST HOC ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEX DIFFERENCE; STENT THROMBOSIS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PACLITAXEL; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SINGLE-BLIND METHOD; SIROLIMUS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; WOMEN'S HEALTH;

EID: 70350593842     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22067     Document Type: Review

References (23)

1. Heron M. Deaths: Leading Causes for 2004. Atlanta: National Center for Health Statistics; 2007.
2. Ayanian JZ, Epstein AM. Differences in the use of procedures between men and women hospitalized for coronary disease. N Engl J Med 1991;325:221-225.
3. Maynard C, Litwin PE, Martin JS, Weaver WD. Gender differences in the treatment and outcome of acute myocardial infarction. Results from the Myocardial Infarction Triage and Intervention Registry. Arch Intern Med 1992;152:972-976.
4. Steingart RM, Packer M, Hamm P, Coglianese ME, Gersh B, Geltman EM, Sollano J, Katz S, Moye L, Basta LL. Sex differences in the management of coronary artery disease. Survival and Ventricular Enlargement Investigators. N Engl J Med 1991;325:226-230.
5. Ellis SG, Roubin GS, King SB III, Douglas JS Jr, Weintraub WS, Thomas RG, Cox WR. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation 1988;77:372-379.
6. Watanabe CT, Maynard C, Ritchie JL. Comparison of shortterm outcomes following coronary artery stenting in men versus women. Am J Cardiol 2001;88:848-852. (Pubitemid 32995916)
7. Argulian E, Patel A, Abramson JL, Kulkarni A, Champney K, Palmer S, Weintraub W, Wenger NK, Vaccarino V. Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions. Am J Cardiol 2006;98: 48-53. (Pubitemid 43902676)
8. Serruys PW, Unger F, Sousa JE, et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001;344:1117-1124. (Pubitemid 32285232)
9. Marx SO, Marks AR. Bench to bedside: The development of rapamycin and its application to stent restenosis. Circulation 2001;104:852-855.
10. Suzuki T, Kopia G, Hayashi S, et al. Stent-based delivery of sirolimus reduces neointimal formation in porcine coronary model. Circulation 2001;104:1188-1193. (Pubitemid 32830406)
11. Axel DI, Kunert W, Goggelmann C, et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 1997;96:636-645. (Pubitemid 27329445)
12. Stone GW, Midei M, Newman W, et al. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: A randomized trial. JAMA 2008; 299:1903-1913. (Pubitemid 351574920)
13. Arnold AM, Mick MJ, Piedmonte MR, Simpfendorfer C. Gender differences for coronary angioplasty. Am J Cardiol 1994; 74:18-21.
14. de Feyter PJ, Serruys PW, Unger F, et al. Bypass surgery versus stenting for the treatment of multivessel disease in patients with unstable angina compared with stable angina. Circulation 2002;105:2367-2372. (Pubitemid 34556387)
15. Bell MR, Grill DE, Garratt KN, Berger PB, Gersh BJ, Holmes DR Jr. Long-term outcome of women compared with men after successful coronary angioplasty. Circulation 1995;91:2876-2881.
16. Berger JS, Sanborn TA, Sherman W, Brown DL. Influence of sex on in-hospital outcomes and long-term survival after contemporary percutaneous coronary intervention. Am Heart J 2006;151:1026-1031. (Pubitemid 44389458)
17. Robertson T, Kennard ED, Mehta S, et al. Influence of gender on in-hospital clinical and angiographic outcomes and on one-year follow-up in the new approaches to coronary intervention (NACI) registry. Am J Cardiol 1997;80:26K-39K. (Pubitemid 28012260)
18. Mehilli J, Kastrati A, Bollwein H, Dibra A, Schuhlen H, Dirschinger J, Schomig A. Gender and restenosis after coronary artery stenting. Eur Heart J 2003;24:1523-1530. (Pubitemid 37010583)
19. Heidland UE, Heintzen MP, Klimek WJ, Michel CJ, Strauer BE. Acute complications and restenosis in women undergoing percutaneous transluminal coronary angioplasty. Is it possible to define sex differences and to determine risk factors? J Cardiovasc Risk 1998;5:297-302.
20. Kelsey SF, James M, Holubkov AL, Holubkov R, Cowley MJ, Detre KM. Results of percutaneous transluminal coronary angioplasty in women. 1985-1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry. Circulation 1993;87:720-727.
21. Lansky AJ. Outcomes of percutaneous and surgical revascularization in women. Prog Cardiovasc Dis 2004;46:305-319. (Pubitemid 38201293)
22. Lansky AJ, Costa RA, Mooney M, et al. Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease. J Am Coll Cardiol 2005;46:1180-1185. (Pubitemid 40523134)
23. Solinas E, Nikolsky E, Lansky AJ, et al. Gender-specific outcomes after sirolimus-eluting stent implantation. J Am Coll Cardiol 2007;50:2111-2116. (Pubitemid 350117340)